To the editor.
We learned with pleasure that The Mediterranean Journal of Hematology and Infectious Diseases had hit a new milestone by obtaining an impact factor of 2.576. We want to congratulate you on this achievement. From our point of view, in a country with poor resources and enthusiastic researchers, the MJHID was a shelter for our papers. This Journal provides three advantages for us. Firstly, English language weakness does not influence the decision, and secondly, it provides a good guide to the researcher to build a good quality project. Thirdly, the communication with the Editor is straightforward without obstacles. Utilizing such advantages, we could have published good papers in the MJHID, gaining readers’ attention and recording good citations.1–5 It is believed that the advantages the MJHID provided to authors have played a role in hitting such a milestone. The new Journal’s achievement should not change its standards to continue encouraging us all the researchers of low-income countries. Therefore, we believe that hitting a new milestone should drive you to increase the help to researchers in the low-income research setting and where the research resources are sparse. We suggest the Journal establish a mentoring committee to help such researchers meet international standards and make necessary amendments to the projects rather than rejecting the papers in the first screening and/or revision round. Finally, in a world full of challenges for researchers who work in an environment that does not appreciate and support research, we hope to support and provide a platform that makes our voice heard.
Footnotes
Competing interests: The authors declare no conflict of Interest.
References
- 1.Hussein NR. The efficacy and safety of sofosbuvir-containing regimen in the treatment of HCV infection in patients with haemoglobinopathy. Mediterranean Journal of Hematology and Infectious Diseases. 2017;9(1):e2017005. doi: 10.4084/mjhid.2017.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hussein NR, Naqid IA, Saleem ZSM. A retrospective descriptive study characterizing coronavirus disease epidemiology among people in the Kurdistan Region, Iraq. Mediterranean Journal of Hematology and Infectious Diseases. 2020;12(1):e2020061. doi: 10.4084/mjhid.2020.061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hussein NR, Naqid IA, Salih HM. The efficacy and safety of intralesional sodium stibogluconate for the treatment of cutaneous Leishmaniasis in children under the age of two years. Mediterranean Journal of Hematology and Infectious Diseases. 2020;12(1):e2020027. doi: 10.4084/mjhid.2020.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hussein NR, Rashad BH, Almizori LA, Yousif SS, Sadeeq AT, Abdulkareem YR, et al. The risk of SARS-CoV-2 reinfection in Duhok city, Kurdistan region of Iraq. Mediterranean Journal of Hematology and Infectious Diseases. 2021;13(1):e2021035. doi: 10.4084/MJHID.2021.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hussein NR, Saleema ZS, Abd QH. Direct acting antiviral treatment for patients with end-stage kidney disease with acute HCV infection. Mediterranean Journal of Hematology and Infectious Diseases. 2019;11(1):e2019034. doi: 10.4084/mjhid.2019.034. [DOI] [PMC free article] [PubMed] [Google Scholar]